Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 27 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of SMS Lifesciences India Ltd

About the Company - SMS Lifesciences India Ltd

SMS Lifesciences India Ltd. is a Public Limited Listed company incorporated on 31/05/2006 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L74930TG2006PLC050223 and registration number is 050223. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 345.63 Cr. and Equity Capital is Rs. 3.02 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No.19-III, Road No.71, Hyderabad Telangana 500096info@smslife.in
http://www.smslife.in
Management
NamePosition Held
Mr. TVVSN MurthyManaging Director
Mr. T V PraveenExecutive Director
Mrs. Sudeepthi GopineediWhole Time Director
Mr. P Sarath KumarIndependent Director
Dr. Srinivas SamavedamIndependent Director
Dr. Mannam MalakondaiahIndependent Director

SMS Lifesciences India Ltd. Share Price Update

Share PriceValue
Today₹590.00
Previous Day₹561.90

Basic Stock Data of SMS Lifesciences India Ltd

Market Cap 183 Cr.
Current Price 606
High / Low707/464
Stock P/E66.2
Book Value 553
Dividend Yield0.26 %
ROCE7.92 %
ROE6.12 %
Face Value 10.0

Data Source: screener.in

Competitors of SMS Lifesciences India Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Marksans Pharma Ltd 7,137 Cr. 158179/64.322.5 41.40.32 %22.2 %18.6 % 1.00
Kwality Pharmaceuticals Ltd 522 Cr. 503545/24818.4 2060.00 %18.5 %16.5 % 10.0
Venus Remedies Ltd 456 Cr. 341430/15115.7 3520.00 %7.75 %5.90 % 10.0
Cipla Ltd 1,17,939 Cr. 1,4611,469/85229.9 3070.59 %18.0 %12.8 % 2.00
Pharmaids Pharmaceuticals Ltd 126 Cr. 58.979.2/19.7 9.600.00 %64.4 %49.1 % 10.0
Industry Average25,236.00 Cr504.3817.30183.200.18%26.17%20.58%6.60

SMS Lifesciences India Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales61.7666.5782.5176.2786.7591.0695.6682.2881.2688.2963.7374.6569.26
Expenses53.7859.8874.0868.0677.1382.5989.2373.7972.9978.9361.4572.1161.40
Operating Profit7.986.698.438.219.628.476.438.498.279.362.282.547.86
OPM %12.92%10.05%10.22%10.76%11.09%9.30%6.72%10.32%10.18%10.60%3.58%3.40%11.35%
Other Income0.280.611.280.078.440.036.640.310.150.504.810.610.34
Interest1.291.070.991.121.821.491.751.641.681.671.802.182.81
Depreciation1.971.971.972.132.692.612.582.592.642.632.923.703.73
Profit before tax5.004.266.755.0313.554.408.744.574.105.562.37-2.731.66
Tax %33.60%36.85%25.04%27.83%24.28%46.82%7.67%49.23%23.66%31.29%10.55%-40.29%126.51%
Net Profit3.312.705.053.6310.252.338.082.323.123.822.11-3.83-0.44
EPS in Rs10.958.9316.7012.0133.907.7126.799.969.1013.205.66-5.95-3.67

SMS Lifesciences India Ltd Quarterly Chart

SMS Lifesciences India Ltd Profit & Loss

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales378261266350316296
Expenses343235235316287274
Operating Profit352530352922
OPM %9%10%11%10%9%7%
Other Income2221456
Interest655678
Depreciation688101113
Profit before tax25152033177
Tax %30%31%31%23%31%
Net Profit18101425112
EPS in Rs59.0433.6744.8583.7537.919.24
Dividend Payout %3%0%3%2%4%

SMS Lifesciences India Ltd Profit & Loss Yearly Chart

Achyut Healthcare Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:7%
TTM:-20%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:-1%
TTM:-79%
Stock Price CAGR
10 Years:%
5 Years:0%
3 Years:0%
1 Year:0%
Return on Equity
10 Years:%
5 Years:%
3 Years:9%
Last Year:6%

SMS Lifesciences India Ltd Balance Sheet

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital333333
Reserves103113126149166164
Borrowings47656580100106
Other Liabilities11672108125126109
Total Liabilities270253302357395383
Fixed Assets118124130142228221
CWIP316385119
Investments000000
Other Assets148113134164166153
Total Assets270253302357395383

SMS Lifesciences India Ltd Reserves and Borrowings Chart

Achyut Healthcare Ltd Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 301535-1115
Cash from Investing Activity -44-27-26-7-31
Cash from Financing Activity 1512-31117
Net Cash Flow1-06-80

SMS Lifesciences India Ltd Financial Efficiency Indicators

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days4030473553
Inventory Days116149164159184
Days Payable140101163146127
Cash Conversion Cycle16784848110
Working Capital Days2747375676
ROCE %12%13%12%8%

SMS Lifesciences India Ltd Financial Efficiency Indicators Chart

SMS Lifesciences India Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters68.26%67.74%67.74%67.69%68.96%69.85%69.85%70.32%70.32%70.32%70.32%70.68%
FIIs0.00%0.00%0.04%0.07%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public31.74%32.26%32.21%32.23%31.04%30.15%30.14%29.69%29.67%29.68%29.68%29.31%
No. of Shareholders9,56310,3299,5808,8438,8418,9398,7998,5938,3498,4758,4438,233

SMS Lifesciences India Ltd Shareholding Pattern Chart

No. of SMS Lifesciences India Ltd Shareholders

This stock is not held by any mutual fund

SMS Lifesciences India Ltd ROCE Trend

SMS Lifesciences India Ltd EPS Trend

SMS Lifesciences India Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)37.9283.6144.8433.6859.03
Diluted EPS (Rs.)37.9283.6144.8433.6859.03
Cash EPS (Rs.)73.32116.7870.8459.6980.14
Book Value[Excl.RevalReserv]/Share (Rs.)622.55545.53427.40382.80351.70
Book Value[Incl.RevalReserv]/Share (Rs.)622.55545.53427.40382.80351.70
Revenue From Operations / Share (Rs.)1043.761156.83878.48862.571249.80
PBDIT / Share (Rs.)105.27119.80105.7191.51123.28
PBIT / Share (Rs.)69.5886.7079.7065.51102.18
PBT / Share (Rs.)54.88108.2664.7248.5283.96
Net Profit / Share (Rs.)37.6383.6844.8433.6859.03
NP After MI And SOA / Share (Rs.)37.9183.7644.8433.6859.03
PBDIT Margin (%)10.0810.3512.0310.609.86
PBIT Margin (%)6.667.499.077.598.17
PBT Margin (%)5.259.357.365.626.71
Net Profit Margin (%)3.607.235.103.904.72
NP After MI And SOA Margin (%)3.637.245.103.904.72
Return on Networth / Equity (%)6.7916.6310.498.7916.78
Return on Capital Employeed (%)8.0411.8412.7711.9421.31
Return On Assets (%)2.907.094.484.026.61
Long Term Debt / Equity (X)0.320.260.300.310.25
Total Debt / Equity (X)0.580.500.450.490.37
Asset Turnover Ratio (%)0.831.130.991.030.00
Current Ratio (X)1.191.151.111.231.14
Quick Ratio (X)0.540.520.560.490.48
Inventory Turnover Ratio (X)2.003.022.242.190.00
Dividend Payout Ratio (NP) (%)3.951.790.000.006.60
Dividend Payout Ratio (CP) (%)2.031.280.000.004.86
Earning Retention Ratio (%)96.0598.210.000.0093.40
Cash Earning Retention Ratio (%)97.9798.720.000.0095.14
Interest Coverage Ratio (X)4.685.877.065.396.77
Interest Coverage Ratio (Post Tax) (X)2.333.043.992.984.24
Enterprise Value (Cr.)271.04295.69197.88102.98204.22
EV / Net Operating Revenue (X)0.850.840.740.390.54
EV / EBITDA (X)8.528.166.193.725.48
MarketCap / Net Operating Revenue (X)0.490.600.560.200.44
Retention Ratios (%)96.0498.200.000.0093.39
Price / BV (X)0.931.381.160.451.57
Price / Net Operating Revenue (X)0.490.600.560.200.44
EarningsYield0.070.120.090.190.10

SMS Lifesciences India Ltd Profitability Ratios (%)

SMS Lifesciences India Ltd Liquidity Ratios

SMS Lifesciences India Ltd Liquidity Ratios (%)

SMS Lifesciences India Ltd Interest Coverage Ratios (X)

SMS Lifesciences India Ltd Valuation Ratios

Fair Value / Intrinsic Value of SMS Lifesciences India Ltd

Fair Value: ₹2246.27

The stock is undervalued by 270.67% compared to the current price ₹606

*Investments are subject to market risks

Strength and Weakness of Ajanta Pharma Ltd

StrengthWeakness
  1. The company has higher reserves (136.83 cr) compared to borrowings (77.17 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (311.17 cr) and profit (19.50 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 80.73 and average Dividend Yield of 7.80%.
  2. The stock has a low average ROCE of 9.00%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 48.60, which may not be favorable.
  4. The stock has a high average Cash Conversion Cycle of 60.00, which may not be favorable.

Should I Buy Achyut Healthcare Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in SMS Lifesciences India Ltd:
    1. Net Profit Margin: 3.60%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 8.04% (Industry Average ROCE: 16.19%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 2.33
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 0.54
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✗ Stock P/E: 61.1 (Industry average Stock P/E: 31.18)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.58
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in SMS Lifesciences India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE